BRÈVE

sur NOVACYT (EPA:ALNOV)

Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement

Graphique de l'évolution du cours de l'action NOVACYT (EPA:ALNOV).

Novacyt, an international specialist in clinical diagnostics, has published its monthly results for August 2024 concerning the liquidity contract entrusted to Invest Securities SA. During this month, 99,268 shares were purchased at a price ranging from €0.52 to €1.35, while 131,896 shares were sold at prices ranging from €0.53 to €1.36.

As of the close of trading on August 31, 2024, the Company held 20,436 ordinary shares in treasury. The total number of ordinary shares is 70,626,248, a figure that may serve as a reference for shareholders wishing to declare or modify their interest in the Company.

Novacyt, a subscriber to the liquidity agreement since 2016, received shareholder approval in July 2024 for share purchases of up to €5.00 per share, for a maximum amount of €200,000. The agreement stipulates that Invest Securities acts independently, and it is remunerated €10,000 per year for its services. This agreement is governed by French law.

R. P.

Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de NOVACYT